KUALA LUMPUR: CGS-CIMB Equities Research deems Pharmaniaga Bhd’s 9M19 core net profit of RM28.7m (-45.2% year-on-year) to be within expectations at 86% of its full-year estimates.
“We are positive on the extensions that Pharmaniaga secured from the Ministry of Health (MOH), but near-term earnings will be weighed down by higher amortisation charges for Pharmacy Hospital Information System (PHIS).
Already a subscriber? Log in.
Subscribe to win RM50 Touch 'n Go e-Voucher! More Info
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!